Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
Clinical trial NCT00290407 · TERMINATED
Trial details
- NCT number
- NCT00290407
- Sponsor
- University of Louisville
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2010-01-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.